MELD-Na Score as a Predictor of Postoperative Complications in Ventral Skull Base Surgery

Abstract

Objective The Model for End-stage Liver Disease-Sodium (MELD-Na) score was designed for prognosis of chronic liver disease and has been predictive of outcomes in a variety of procedures. Few studies have investigated its utility in otolaryngology. This study uses the MELD-Na score to investigate the association between liver health and ventral skull base surgical complications.

Methods The National Surgical Quality Improvement Program database was used to identify patients who underwent ventral skull base procedures between 2005 and 2015. Univariate and multivariate analyses were performed to investigate the association between elevated MELD-Na score and postoperative complications.

Results We identified 1,077 patients undergoing ventral skull base surgery with laboratory values required to calculate the MELD-Na score. The mean age was 54.2 years. The mean MELD-Na score was 7.70 (standard deviation = 2.04). Univariate analysis showed that elevated MELD-Na score was significantly associated with increased age (58.6 vs 53.8 years) and male gender (70.8 vs 46.1%). Elevated MELD-Na score was associated with increased rates of postoperative acute renal failure, transfusion, septic shock, surgical complications, and extended length of hospital stay. On multivariate analysis, associations between elevated MELD-Na and increased risk of perioperative transfusions (odds ratio [OR], 1.62; 95% confidence interval [CI], 1.20–2.93; p = 0.007) and surgical complications (OR, 1.58; 95% CI, 1.25–2.35; p = 0.009) remained significant.

Conclusions This analysis points to an association between liver health and postoperative complications in ventral skull base surgery. Future research investigating this association is warranted.

Keywords

ventral skull base - MELD-Na - head and neck surgery - complications

Presented as a Poster at the Triological Society 2021 Combined Sections Virtual Meeting, January 29–30, 2021.

Publikationsverlauf

Eingereicht: 20. September 2021

Angenommen: 01. Mai 2022

Accepted Manuscript online:
04. Mai 2022

Artikel online veröffentlicht:
18. Juli 2022

• References

• 1 Villarroel MA, Blackwell DL, Jen A. Tables of Summary Health Statistics for U.S. Adults: 2018 National Health Interview Survey. National Center for Health Statistics; 2019
• 2 Hirode G, Saab S, Wong RJ. Trends in the burden of chronic liver disease among hospitalized US adults. JAMA Netw Open 2020; 3 (04) e201997
• 3 Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004; 188 (05) 580-583
• 4 Bhangui P, Laurent A, Amathieu R, Azoulay D. Assessment of risk for non-hepatic surgery in cirrhotic patients. J Hepatol 2012; 57 (04) 874-884
• 5 Havens JM, Columbus AB, Olufajo OA, Askari R, Salim A, Christopher KB. Association of model for end-stage liver disease score with mortality in emergency general surgery patients. JAMA Surg 2016; 151 (07) e160789
• 6 Cramer JD, Patel UA, Samant S, Yang A, Smith SS. Liver disease in patients undergoing head and neck surgery: Incidence and risk for postoperative complications. Laryngoscope 2017; 127 (01) 102-109
• 7 Neeff H, Mariaskin D, Spangenberg HC, Hopt UT, Makowiec F. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores. J Gastrointest Surg 2011; 15 (01) 1-11
• 8 Muilenburg DJ, Singh A, Torzilli G, Khatri VP. Surgery in the patient with liver disease. Med Clin North Am 2009; 93 (05) 1065-1081
• 9 Teh SH, Nagorney DM, Stevens SR. et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007; 132 (04) 1261-1269
• 10 Kao HK, Chang KP, Ching WC, Tsao CK, Cheng MH, Wei FC. The impacts of liver cirrhosis on head and neck cancer patients undergoing microsurgical free tissue transfer: an evaluation of flap outcome and flap-related complications. Oral Oncol 2009; 45 (12) 1058-1062
• 11 Kao H-K, Guo L-F, Cheng M-H. et al. Predicting postoperative morbidity and mortality by model for endstage liver disease score for patients with head and neck cancer and liver cirrhosis. Head Neck 2011; 33 (04) 529-534
• 12 Baert M, Pascual C, Hautefeuille V, Nguyen-Khac E, Page C. Effect of liver disease on post-therapeutic complications of head and neck squamous cell carcinoma. A prospective study of 94 patients. Clin Otolaryngol 2020; 45 (02) 292-296
• 13 Srivastava A, Ghosh A, Saha S, Saha VP, Chakraborty D. Sarcomas of head and neck - A 10 yrs experience. Indian J Otolaryngol Head Neck Surg 2007; 59 (04) 322-326
• 14 Wahlang B, Beier JI, Clair HB. et al. Toxicant-associated steatohepatitis. Toxicol Pathol 2013; 41 (02) 343-360
• 15 Naka T, Kuester D, Boltze C. et al. Expression of hepatocyte growth factor and c-MET in skull base chordoma. Cancer 2008; 112 (01) 104-110
• 16 Goel NJ, Abdullah KG, Choudhri OA, Kung DK, Lucas TH, Chen HI. The effect of underlying liver disease on perioperative outcomes following craniotomy for tumor: an American College of Surgeons National Quality Improvement Program analysis. World Neurosurg 2018; 115: e85-e96
• 17 Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31 (04) 864-871
• 18 Kamath PS, Wiesner RH, Malinchoc M. et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33 (02) 464-470
• 19 Kim WR, Biggins SW, Kremers WK. et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359 (10) 1018-1026
• 20 Martini A, Ceranto E, Gatta A, Angeli P, Pontisso P. Occult liver disease burden: analysis from a large general practitioners' database. United European Gastroenterol J 2017; 5 (07) 982-986
• 21 Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013; 58 (03) 593-608
• 22 Guss D, Sherigar J, Mohanty SR. Missed diagnosis of liver cirrhosis leads to disparities in care for older patients. Gastroenterol Res 2018; 11 (05) 333-339
• 23 Marcellin P, Kutala BK. Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int 2018; 38 (Suppl. 01) 2-6
• 24 Borg A, Kirkman MA, Choi D. Endoscopic endonasal anterior skull base surgery: a systematic review of complications during the past 65 years. World Neurosurg 2016; 95: 383-391
• 25 Kutlay M, Durmaz A, Özer İ. et al. Extended endoscopic endonasal approach to the ventral skull base lesions. Clin Neurol Neurosurg 2018; 167: 129-140
• 26 Singh R, Siddiqui SH, Choi Y. et al. Morbidity and mortality associated with ventral skull base surgery: analysis of the National Surgical Quality Improvement Program. Int Forum Allergy Rhinol 2019; 9 (12) 1485-1491
• 27 Schlosser KA, Kao AM, Zhang Y. et al. MELD-Na score associated with postoperative complications in hernia repair in non-cirrhotic patients. Hernia 2019; 23 (01) 51-59
• 28 Pollock KJ, Casiano RR, Folbe AJ, Golfinos JG, Snyderman CH. and the NASBS Best Practices for Coding & Billing Task Force. Coding and reimbursement for endoscopic endonasal surgery of the skull base. J Neurol Surg B Skull Base 2019; 80 (Suppl. 02) S247-S254
• 29 Hsu CY, Lin HC, Huang YH. et al. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis. Dig Liver Dis 2010; 42 (02) 137-142
• 30 Choden T, Satoskar R. MELD-Na: does this leave anyone behind?. Curr Hepatol Rep 2017; 16 (03) 220-227
• 31 Goudsmit BFJ, Putter H, Tushuizen ME. et al. Validation of the model for end-stage liver disease sodium (MELD-Na) score in the Eurotransplant region. Am J Transplant 2021; 21 (01) 229-240
• 32 Kim BJ, Tzeng CD, Cooper AB, Vauthey J-N, Aloia TA. Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications. J Surg Oncol 2017; 115 (03) 337-343
• 33 ABIM laboratory test reference ranges. January 2020. Accessed October 13, 2020 at: https://www.abim.org/~/media/ABIM%20Public/Files/pdf/exam/laboratory-reference-ranges.pdf
• 34 Povolotskiy R, Cerasiello SY, Siddiqui SH, Baredes S, Eloy JA, Hsueh WD. Anemia and blood transfusion requirements in endoscopic sinus surgery: a propensity-matched analysis. Laryngoscope 2020; 130 (06) 1377-1382
• 35 User Guide for the 2014 ACS NSQIP Participant Use Data File. American College of Surgeons; 2015
• 36 Filimonov A, Chung SY, Wong A, Brady JS, Baredes S, Eloy JA. Effect of diabetes mellitus on postoperative endoscopic sinus surgery outcomes. Int Forum Allergy Rhinol 2017; 7 (06) 584-590
• 37 Kuhn M, Johnson K. Applied Predictive Modeling. New York, NY: Springer; 2013
• 38 Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology 2014; 59 (04) 1627-1637
• 39 Salamone G, Licari L, Guercio G. et al. The abdominal wall hernia in cirrhotic patients: a historical challenge. World J Emerg Surg 2018; 13 (01) 35